E Hope Weissler1, J Antonio Gutierrez2,3, Manesh R Patel2,3, Rajesh V Swaminathan4,5. 1. Division of Vascular and Endovascular Surgery, Duke University School of Medicine, Durham, NC, USA. 2. Division of Cardiology, Duke University School of Medicine, Durham, NC, USA. 3. Duke University Medical Center, Duke Clinical Research Institute, 200 Morris St, Durham, NC, 27705, USA. 4. Division of Cardiology, Duke University School of Medicine, Durham, NC, USA. rajesh@duke.edu. 5. Duke University Medical Center, Duke Clinical Research Institute, 200 Morris St, Durham, NC, 27705, USA. rajesh@duke.edu.
Abstract
PURPOSE OF REVIEW: Certain comorbidities and lesion characteristics are associated with increased risk for procedural complications, limb events, and cardiovascular events following peripheral vascular intervention (PVI) in patients with peripheral arterial disease (PAD). The purpose of this review is to provide an overview of high-risk modifiable and unmodifiable patient characteristics and its relative impact on clinical outcomes such as amputation risk and mortality. Furthermore, general approaches to potentially mitigating these risks through pre-intervention planning and use of modern devices and techniques are discussed. RECENT FINDINGS: Diabetes, tobacco use, and older age remain strong risk factors for the development of peripheral arterial disease. Recent data highlight the significant risk of polyvascular disease on major limb and cardiac events in advanced PAD, and ongoing studies are assessing this risk specifically after PVI. Challenging lesion characteristics such as calcified disease and chronic total occlusions can be successfully treated with PVI by utilizing novel devices (e.g., intravascular lithotripsy, re-entry devices) and techniques (e.g., subintimal arterial "flossing" with antegrade-retrograde intervention). Understanding high-risk patient comorbidities and lesion characteristics will improve our ability to counsel and manage patients with advanced PAD. Continued device innovation and novel techniques will aid in procedural planning for successful interventions to improve clinical outcomes.
PURPOSE OF REVIEW: Certain comorbidities and lesion characteristics are associated with increased risk for procedural complications, limb events, and cardiovascular events following peripheral vascular intervention (PVI) in patients with peripheral arterial disease (PAD). The purpose of this review is to provide an overview of high-risk modifiable and unmodifiable patient characteristics and its relative impact on clinical outcomes such as amputation risk and mortality. Furthermore, general approaches to potentially mitigating these risks through pre-intervention planning and use of modern devices and techniques are discussed. RECENT FINDINGS:Diabetes, tobacco use, and older age remain strong risk factors for the development of peripheral arterial disease. Recent data highlight the significant risk of polyvascular disease on major limb and cardiac events in advanced PAD, and ongoing studies are assessing this risk specifically after PVI. Challenging lesion characteristics such as calcified disease and chronic total occlusions can be successfully treated with PVI by utilizing novel devices (e.g., intravascular lithotripsy, re-entry devices) and techniques (e.g., subintimal arterial "flossing" with antegrade-retrograde intervention). Understanding high-risk patient comorbidities and lesion characteristics will improve our ability to counsel and manage patients with advanced PAD. Continued device innovation and novel techniques will aid in procedural planning for successful interventions to improve clinical outcomes.
Authors: Cecilia C Low Wang; Juuso I Blomster; Gretchen Heizer; Jeffrey S Berger; Iris Baumgartner; F Gerry R Fowkes; Peter Held; Brian G Katona; Lars Norgren; W Schuyler Jones; Renato D Lopes; Jeffrey W Olin; Frank W Rockhold; Kenneth W Mahaffey; Manesh R Patel; William R Hiatt Journal: J Am Coll Cardiol Date: 2018-12-25 Impact factor: 24.094
Authors: Virendra I Patel; Shankha Mukhopadhyay; Julie M Guest; Mark F Conrad; Michael T Watkins; Christopher J Kwolek; Glenn M LaMuraglia; Richard P Cambria Journal: J Vasc Surg Date: 2013-10-28 Impact factor: 4.268
Authors: Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh Journal: J Am Coll Cardiol Date: 2016-11-13 Impact factor: 24.094
Authors: Michael S Conte; Andrew W Bradbury; Philippe Kolh; John V White; Florian Dick; Robert Fitridge; Joseph L Mills; Jean-Baptiste Ricco; Kalkunte R Suresh; M Hassan Murad Journal: J Vasc Surg Date: 2019-05-28 Impact factor: 4.268
Authors: Paul P Heideman; Mohammad Reza Rajebi; Michael A McKusick; Haraldur Bjarnason; Gustavo S Oderich; Jeremy L Friese; Mark D Fleming; Andrew H Stockland; William S Harmsen; Jay Mandrekar; Sanjay Misra Journal: J Vasc Interv Radiol Date: 2016-06-16 Impact factor: 3.464
Authors: Steven T W van Haelst; Saskia Haitjema; Jean-Paul P M de Vries; Frans L Moll; Gerard Pasterkamp; Hester M den Ruijter; Gert J de Borst Journal: J Vasc Surg Date: 2016-09-22 Impact factor: 4.268
Authors: Alexander T Hawkins; Maria J Schaumeier; Ann D Smith; Nathanael D Hevelone; Louis L Nguyen Journal: Ann Vasc Surg Date: 2014-01 Impact factor: 1.607